Philips launches IntraSight Plus to streamline coronary procedures and improve patient care with 47% time savings.

Royal Philips has launched IntraSight Plus, an advanced interventional cardiology platform cleared by the FDA and CE marked in Europe. This system integrates diagnostic and treatment planning tools into a single interface, enabling clinicians to perform coronary interventions more efficiently and precisely. It can reduce system operation time by up to 47%, supporting better decision-making and patient outcomes in minimally invasive procedures. The platform also connects seamlessly with Philips' Azurion system, enhancing workflow in catheterization labs.